UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Smokers run increased risk of developing anti-natalizumab antibodies

Multiple sclerosis, 2014-07, Vol.20 (8), p.1081-1085

2014

Volltextzugriff (PDF)

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment

PloS one, 2019-02, Vol.14 (2), p.e0210463-e0210463

2019

Volltextzugriff (PDF)

Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier

Frontiers in immunology, 2020-07, Vol.11, p.1365-1365

2020

Volltextzugriff (PDF)

Resorbable and Highly Elastic Block Copolymers from 1,5-Dioxepan-2-one and l-Lactide with Controlled Tensile Properties and Hydrophilicity

Biomacromolecules, 2002-05, Vol.3 (3), p.601-608

2002

Volltextzugriff (PDF)

Mechanism of Ring-Opening Polymerization of 1,5-Dioxepan-2-one and l-Lactide with Stannous 2-Ethylhexanoate. A Theoretical Study

Macromolecules, 2001-06, Vol.34 (12), p.3877-3881

2001

Volltextzugriff (PDF)

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

Multiple sclerosis, 2018-08, Vol.24 (9), p.1224-1233

2018

Volltextzugriff (PDF)

Climatic and hydrological instability in semi-arid equatorial East Africa during the late Glacial to Holocene transition: A multi-proxy reconstruction of aquatic ecosystem response in northern Tanzania

Palaeogeography, palaeoclimatology, palaeoecology, 2007-05, Vol.248 (3), p.440-458

2007

Volltextzugriff (PDF)

Ring-Opening Polymerization of Lactones and Lactides with Sn(IV) and Al(III) Initiators

Macromolecules, 2002-02, Vol.35 (5), p.1556-1562

2002

Volltextzugriff (PDF)

The (International) Political Economy of Falling Wage Shares: Situating Working-Class Agency

New political economy, 2015-05, Vol.20 (3), p.406-430

2015

Volltextzugriff (PDF)

Dihydroxy-Terminated Poly(l-lactide) Obtained by Controlled Ring-Opening Polymerization: Investigation of the Polymerization Mechanism

Macromolecules, 2000-04, Vol.33 (8), p.2862-2869

2000

Volltextzugriff (PDF)

l-Lactide Macromonomer Synthesis Initiated by New Cyclic Tin Alkoxides Functionalized for Brushlike Structures

Macromolecules, 2001-10, Vol.34 (21), p.7281-7287

2001

Volltextzugriff (PDF)

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

Arthritis research & therapy, 2021-08, Vol.23 (1), p.1-211, Article 211

2021

Volltextzugriff (PDF)

Trachomatous Scar Ranking: A Novel Outcome for Trachoma Studies

The American journal of tropical medicine and hygiene, 2017-06, Vol.96 (6), p.1378-1381

2017

Volltextzugriff (PDF)

Prediction of natalizumab anti-drug antibodies persistency

Multiple sclerosis, 2019-03, Vol.25 (3), p.392-398

2019

Volltextzugriff (PDF)

Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis

Journal of neuroimmunology, 2022-09, Vol.370, p.577932-577932, Article 577932

2022

Volltextzugriff (PDF)

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

BMC medicine, 2020-11, Vol.18 (1), p.298-298, Article 298

2020

Volltextzugriff (PDF)

Controlled Ring-Opening Polymerization: Polymers with designed Macromolecular Architecture

Advances in polymer science, 2002-01, Vol.157, p.41-65

2002

Volltextzugriff (PDF)

12,000-Year, preliminary results of the stable nitrogen and carbon isotope record from the Empakai Crater lake sediments, Northern Tanzania

Journal of African earth sciences (1994), 2004-12, Vol.40 (5), p.293-303

2004

Volltextzugriff (PDF)

Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a

Multiple sclerosis, 2014-04, Vol.20 (4), p.445-450

2014

Volltextzugriff (PDF)

Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta

Multiple sclerosis and related disorders, 2022-07, Vol.63, p.103815-103815, Article 103815

2022

Volltextzugriff (PDF)

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A

PloS one, 2019-06, Vol.14 (6), p.e0218258-e0218258

2019

Volltextzugriff (PDF)

Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta

Journal of immunological methods, 2016-03, Vol.430, p.1-9

2016

Volltextzugriff (PDF)

Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosis

PloS one, 2014-03, Vol.9 (3), p.e90479-e90479

2014

Volltextzugriff (PDF)

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, Vol.51, p.386

2021

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(90)

Publikationsform

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Smokers run increased risk of developing anti-natalizumab antibodies

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment

Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier

Resorbable and Highly Elastic Block Copolymers from 1,5-Dioxepan-2-one and l-Lactide with Controlled Tensile Properties and Hydrophilicity

Mechanism of Ring-Opening Polymerization of 1,5-Dioxepan-2-one and l-Lactide with Stannous 2-Ethylhexanoate. A Theoretical Study

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies

Climatic and hydrological instability in semi-arid equatorial East Africa during the late Glacial to Holocene transition: A multi-proxy reconstruction of aquatic ecosystem response in northern Tanzania

Ring-Opening Polymerization of Lactones and Lactides with Sn(IV) and Al(III) Initiators

The (International) Political Economy of Falling Wage Shares: Situating Working-Class Agency

Dihydroxy-Terminated Poly(l-lactide) Obtained by Controlled Ring-Opening Polymerization: Investigation of the Polymerization Mechanism

l-Lactide Macromonomer Synthesis Initiated by New Cyclic Tin Alkoxides Functionalized for Brushlike Structures

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

Trachomatous Scar Ranking: A Novel Outcome for Trachoma Studies

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

Prediction of natalizumab anti-drug antibodies persistency

Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

Controlled Ring-Opening Polymerization: Polymers with designed Macromolecular Architecture

12,000-Year, preliminary results of the stable nitrogen and carbon isotope record from the Empakai Crater lake sediments, Northern Tanzania

Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a

Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A

Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta

Human leukocyte antigen genes and interferon beta preparations influence risk of developing neutralizing anti-drug antibodies in multiple sclerosis

First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis

Aktive Filter

Suchergebnisse filtern